menu
    • menu

    Company profile for Opus Genetics

    NEW Drugs in Dev: 10
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Opus Genetics is a patient-first, science driven gene therapy company tackling manufacturing obstacles standing in the way of treatments for ultra-rare blinding conditions.Opus Genetics is a groundbreaking gene therapy company for inherited retinal diseases with a unique model and purpose. Backed by Foundation Fighting Blindness’s venture arm, the RD Fund, Opus combines unparalleled insight and commitment to patient need wit...
    Opus Genetics is a patient-first, science driven gene therapy company tackling manufacturing obstacles standing in the way of treatments for ultra-rare blinding conditions.Opus Genetics is a groundbreaking gene therapy company for inherited retinal diseases with a unique model and purpose. Backed by Foundation Fighting Blindness’s venture arm, the RD Fund, Opus combines unparalleled insight and commitment to patient need with wholly owned programs in numerous orphan retinal diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Opus GeneticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    37000 Grand River Avenue, Suite 120, Farmington Hills, MI 48335
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://opusgtx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/opus-genetics/?viewAsMember=true
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/OpusGenetics

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Opus Genetics Reports Q1 2026 Financials And Corporate Update
    Opus Genetics Reports Q1 2026 Financials And Corporate Update

    12 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/12/3292661/0/en/opus-genetics-announces-financial-results-for-first-quarter-2026-and-provides-corporate-update.html

    GLOBENEWSWIRE
    12 May 2026
    Share Share
    Opus Genetics Presents Pipeline Data at ARVO 2026
    Opus Genetics Presents Pipeline Data at ARVO 2026

    07 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/07/3290656/0/en/opus-genetics-presents-clinical-and-preclinical-data-at-arvo-2026-demonstrating-continued-pipeline-advancement-in-inherited-retinal-diseases.html

    GLOBENEWSWIRE
    07 May 2026
    Share Share
    Opus Genetics Gets FDA Acceptance of OPGx-LCA5 Into RDEP Program
    Opus Genetics Gets FDA Acceptance of OPGx-LCA5 Into RDEP Program

    04 May 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7268239

    FIRSTWORD PHARMA
    04 May 2026
    Share Share
    Opus Genetics To Present At May 2026 Medical Conferences
    Opus Genetics To Present At May 2026 Medical Conferences

    27 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/27/3281557/0/en/opus-genetics-to-participate-in-leading-medical-conferences-in-may-2026.html

    GLOBENEWSWIRE
    27 Apr 2026
    Share Share
    Opus Genetics Presents Data At 2026 Ascrs Annual Meeting
    Opus Genetics Presents Data At 2026 Ascrs Annual Meeting

    10 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/10/3271649/0/en/Opus-Genetics-Announces-Data-Presentations-at-the-2026-American-Society-of-Cataract-and-Refractive-Surgery-Annual-Meeting.html

    GLOBENEWSWIRE
    10 Apr 2026
    Share Share
    Opus Genetics Secures Oberland Funding for Retinal Therapy
    Opus Genetics Secures Oberland Funding for Retinal Therapy

    06 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/06/3268337/0/en/Opus-Genetics-Solidifies-Leadership-Position-in-Gene-Therapy-Development-for-Inherited-Retinal-Diseases-with-Strategic-Long-Term-Financing-by-Oberland-Capital.html

    GLOBENEWSWIRE
    06 Apr 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search